eli lilly news - Search News

The FDA just approved Eli Lilly's Zepbound for sleep apnea

FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity.

Hosted on MSN · 1h

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.

USA Today · 40m

Zepbound helps shed more weight than Wegovy, Eli Lilly study says

A new study put Eli Lilly's Zepbound and Novo Nordisk's Wegovy to the test. Here's which one will help you lose more weight.

Novo, Eli Lilly

Barron's on MSN · 1h

Novo Nordisk Stock Crashes More Than 20% After Disappointing Obesity Drug Data. Eli Lilly Shares Soar.

Novo Nordisk has told the world it expects patients to lose “at least 25%” of their body weight on its experimental drug CagriSema.It turns out the company was wrong.On Friday, Novo released the results of a large Phase 3 trial of the drug.

YAHOO!Finance · 6h

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up

As of 11:05 a.m. ET, Novo Nordisk stock is down a disheartening 20.8%, while both Lilly and Viking stocks are up 4.4% apiece.

MarketWatch · 3h

Eli Lilly & Co. stock outperforms competitors on strong trading day

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Back To Top

GlobalData on MSN11h

FDA confirms end of Eli Lilly’s tirzepatide shortage after re-evaluation

The FDA declared the tirzepatide shortage over in October 2023, but a lawsuit by Outsourcing Facilities Association, a trade ...

Ibj.com6h

Lilly stock caught up in wave of uncertainty

After a stunning 703% run-up in price over the past five years, shares of Eli Lilly and Co. have been on a roller-coaster ...

20hon MSN

Jim Cramer on Eli Lilly and Company (LLY): ‘I See Things Going Back To Normal For Eli Lilly’

We recently compiled a list of the 6 Stocks Jim Cramer Talked About This Week. In this article, we are going to take a look ...

This Is Huge News for Eli Lilly Investors

The hottest area among healthcare investors right now revolves around advancements being made in weight loss. Known as ...

FiercePharma1d

FDA reaffirms decision to erase Eli Lilly's tirzepatide from shortage list, halting future flow of knockoffs

The FDA has doubled down on its decision to remove Eli Lilly’s tirzepatide from its list of products that are in shortage. | ...

16h

In weight loss battle, Novo and Lilly face growing offensive from licensed copies

As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...

12h

Premarket movers: FedEx, Eli Lilly, Nike

FedEx Corp shares increased 9% in Friday's premarket session after the package delivery company outlined plans to spin off its FedEx Freight trucking business Eli Lilly s ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

The FDA just approved Eli Lilly's Zepbound for sleep apnea

Novo, Eli Lilly

Related topics